These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8050491)

  • 1. Are LIF and related cytokines functionally equivalent?
    Piquet-Pellorce C; Grey L; Mereau A; Heath JK
    Exp Cell Res; 1994 Aug; 213(2):340-7. PubMed ID: 8050491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of SSEA-1- and Oct-4-expressing rat embryonic stem-like cell lines and effects of cytokines of the IL-6 family on clonal growth.
    Vassilieva S; Guan K; Pich U; Wobus AM
    Exp Cell Res; 2000 Aug; 258(2):361-73. PubMed ID: 10896787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
    Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia inhibitory factor and neurotrophins support overlapping populations of rat nodose sensory neurons in culture.
    Thaler CD; Suhr L; Ip N; Katz DM
    Dev Biol; 1994 Feb; 161(2):338-44. PubMed ID: 8313987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
    Hui W; Bell M; Carroll G
    Cytokine; 1996 Jun; 8(6):495-500. PubMed ID: 8818547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
    Terada S; Suzuki E; Ueda H; Makishima F
    Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ciliary neurotrophic factor-sensitive human myeloma cell line.
    Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
    Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
    Gearing DP; Bruce AG
    New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
    Klausen P; Pedersen L; Jurlander J; Baumann H
    Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cartilage proteoglycan metabolism by LIF binding protein.
    Hui W; Bell MC; Carroll GJ; Layton MJ
    Cytokine; 1998 Mar; 10(3):220-6. PubMed ID: 9576068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and biological activity of murine oncostatin M.
    Hara T; Ichihara M; Yoshimura A; Miyajima A
    Leukemia; 1997 Apr; 11 Suppl 3():449-50. PubMed ID: 9209421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6.
    Viswanathan S; Benatar T; Rose-John S; Lauffenburger DA; Zandstra PW
    Stem Cells; 2002; 20(2):119-38. PubMed ID: 11897869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.
    Dani C; Chambers I; Johnstone S; Robertson M; Ebrahimi B; Saito M; Taga T; Li M; Burdon T; Nichols J; Smith A
    Dev Biol; 1998 Nov; 203(1):149-62. PubMed ID: 9806780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.